Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 30

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Helicobacter Pylori

World J Gastroenterol. Aug 14, 2005; 11(30): 4715-4720
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4715

Table 1 Baseline characteristics of all patients

¹HC: healthy control; ²DU: duodenal ulcer; ³GU: gastric ulcer; ⁴GC: gastric cancer.

^aP<0.05 vs healthy control group.

Citation: Lo CC, Hsu PI, Lo GH, Lai KH, Tseng HH, Lin CK, Chan HH, Tsai WL, Chen WC, Peng NJ. Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome. World J Gastroenterol 2005; 11(30): 4715-4720
URL: https://www.wjgnet.com/1007-9327/full/v11/i30/4715.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i30.4715

Lo CC, Hsu PI, Lo GH, Lai KH, Tseng HH, Lin CK, Chan HH, Tsai WL, Chen WC, Peng NJ. Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome. World J Gastroenterol 2005; 11(30): 4715-4720 [PMID: 16094716 DOI: 10.3748/wjg.v11.i30.4715]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.